Cosentyx
Targeted IL-17A inhibition for plaque psoriasis and inflammatory skin disease.
Cosentyx (secukinumab) blocks interleukin-17A, one of the central signals that drives plaque psoriasis, psoriatic arthritis and axial inflammation. Rather than suppressing the immune system broadly, it interrupts a single pathway — which is why clearance is often rapid and side effects fewer than with older systemic drugs.
- Injection
- Route
- 4 weekly
- Interval
- 4–12 wks
- First results
- IL-17A
- Target
- Pre-treatment screening
- Weekly induction
- 4-weekly maintenance
- Severity scoring
Diagnosed first, treated second.
Candidacy is decided on disease severity, prior therapy, screening bloodwork and infection history. Treatment is delivered as a subcutaneous injection: weekly loading doses, then a maintenance dose every four weeks, with disease activity scored at each review.
- 01Pre-treatment screening
- 02Weekly induction
- 034-weekly maintenance
- 04Severity scoring
- 05Self-injection training
- Moderate to severe plaque psoriasis
- Inadequate response to topicals or phototherapy
- Psoriatic arthritis with skin involvement
- Intolerance to methotrexate or ciclosporin
- No active infection or untreated tuberculosis
How the treatment works
A sequence, not a single appointment — each step informs the next.
- 01
Eligibility review
Severity scoring, prior treatment history and a full assessment of comorbidities.
- 02
Screening
Tuberculosis screening, hepatitis serology and baseline bloodwork before the first dose.
- 03
Induction
Weekly loading injections for five weeks, taught for confident self-administration at home.
- 04
Maintenance
One injection every four weeks with scored reviews and dose continuation decided on response.
Results measured, not promised.
What to expect
- 01Visible clearance within four to twelve weeks
- 02Relief from itch, scaling and plaque thickness
- 03Reduced joint pain in psoriatic arthritis
- 04Durable remission on maintenance dosing
- 05No routine liver or renal monitoring burden
Begin with a diagnosis,
not a guess.
Share a few details and the clinic will reply with available consultation times for cosentyx — one-to-one with Dr. Arely.
- Response
- Within 24 hours
- Consultation
- One-to-one, 45 min
- Assessment
- Trichoscopy included
- Location
- Dr. Arely Clinic
Frequently asked
Many patients see substantial clearance by week four, with the strongest response between weeks twelve and sixteen.
Yes. You are taught injection technique and storage in clinic, and supported through the first cycles.
It has an extensive safety record. Mild upper respiratory infections and candida are the most common issues; screening reduces risk.
Disease usually returns gradually. Any pause is planned rather than abrupt, with a maintenance strategy agreed first.